We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EE:NYSEExcelerate Energy, Inc. Analysis

Data as of 2026-03-30 - not real-time

$33.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Excelerate Energy, Inc. (EE) is trading at $33.59, comfortably above its nearest support of $32.60 but well below the DCF‑derived fair value of $38.62, implying roughly a 30% upside potential. The company posted a record $449 million adjusted EBITDA for 2025 and is growing revenue at a robust 15.7% YoY, backed by strong operating margins (33% operating margin) and a healthy free cash flow generation of $208 million. With a modest dividend yield of 0.9% and a low payout ratio of 22%, the dividend appears sustainable, while the forward PE of 10.75 suggests earnings are expected to accelerate.
On the technical side, the stock sits below its 20‑day (≈$34.98) and 50‑day (≈$37.04) moving averages, the RSI is at 41, and the MACD histogram is negative, all pointing to short‑term bearish momentum. However, volatility is elevated at nearly 49% and beta is low (~0.56), tempering market‑wide risk. Decreasing volume and a neutral trend signal caution, but the fundamental catalysts—record EBITDA, strategic LNG regasification projects, and upcoming investor conference exposure—support a medium‑to‑long‑term upside thesis.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support level with bearish MACD/RSI
  • Decreasing trading volume
  • Strong fundamentals but short‑term technical weakness

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 30% upside to DCF fair value
  • Record EBITDA and 15.7% revenue growth
  • Upcoming investor conference boosting visibility

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term LNG demand growth
  • Undervalued relative to fair value and sector peers
  • Sustainable dividend and solid cash‑flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth15.70%
Profit Margin3.19%
P/E Ratio26.2
ROE8.11%
ROA5.36%
Debt/Equity64.66
P/B Ratio1.6
Op. Cash Flow$461.2M
Free Cash Flow$208.1M
Industry P/E24.1

Technical Analysis

TrendNeutral
RSI41.2
Support$32.60
Resistance$43.17
MA 20$34.98
MA 50$37.04
MA 200$29.20
MACDBearish
VolumeDecreasing
Fear & Greed Index68.13

Valuation

Fair Value$38.62
Target Price$43.75
Upside/Downside30.25%
GradeUndervalued
TypeBlend
Dividend Yield0.90%

Risk Assessment

Beta0.56
Volatility48.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.